Insider Purchases: Inside the Buy

Tag: MedTech

AngioDynamics logo stylized as a heart monitor, stock chart pulsing upward, surgical tools in background.

AngioDynamics (ANGO)’s CEO Bought Shares a Year Ago and Stock Doubled Since: Will They Keep Going Higher?

AngioDynamics insiders bought low and doubled up, while Wall Street funds practically own the company. With MedTech sales surging and earnings around the corner, can $ANGO climb higher — or will tariffs and volatility zap the gains?

Read entire article

Tags: AngioDynamics, ANGO, ANGO Stock, Buy ANGO, CEO buy, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, Funanc1al, Funanc1al Edge, Funanc1al Humor, Funanc1al Investing, InsiderBuying, Investing, MedTech, StocksToWatch, Turnaround
A colorful, cartoon-style infographic highlighting MiMedx Group (MDXG) as a wound care company. It features icons representing placental tissue grafts, financial growth charts, insider buying, surgical applications, and a confident CEO.

This Wound Care Stock Doesn't Have to Hurt! 🩸🩼

CEO Joseph Capper is buying big. The company’s 9% full-year sales growth and 20%+ EBITDA margins suggest something’s brewing at this placental powerhouse. From PURION™ to profitability—this is wound care with a serious upside.

Read entire article

Tags: BiotechStocks, CEO insider buying, CEOBuyIn, EarningsBeat, Funanc1al Investing, GrowthWithGrit, HealthTech, insider buying, Insider Buys, Insider Purchases, insider trading, InsiderPurchases, MDXG, MedTech, value stocks, ValuePlay